Autolus Therapeutics plc (AUTL) Discusses Advances in B-cell Precursor Acute Lymphoblastic Leukemia Treatment and Clinical Trial Insights Transcript [Seeking Alpha]
Autolus Therapeutics plc - American Depositary Shares (AUTL)
Last autolus therapeutics plc - american depositary shares earnings: 11/7 07:06 am
Check Earnings Report
US:NASDAQ Investor Relations:
autolus.com/investor-relations
Company Research
Source: Seeking Alpha
Company Participants Amanda Cray - Executive Director of Investor Relations & External Communications Matthias Will - Senior VP & Chief Development Officer Christian Itin - CEO & Director Conference Call Participants Jae H. Park Lori Muffly Elias Jabbour Michael Pulsipher Presentation Operator Good day, everyone, and welcome to the Autolus investor event, Spotlight on Acute Lymphoblastic Leukemia, ALL, Program. [Operator Instructions] Now it's my pleasure to turn the call over to Amanda Cray. Please proceed. Amanda Cray Executive Director of Investor Relations & External Communications Thank you, Carmen. Good afternoon or good evening, everyone, and thank you for joining us for today's presentation. With me are Chief Executive Officer, Dr. Christian Itin; and Chief Development Officer, Dr. Matthias Will. Before we get started, I'd like to remind you that during today's call, we will make statements related to our business that are forward-looking under
Show less
Read more
Impact Snapshot
Event Time:
AUTL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AUTL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AUTL alerts
High impacting Autolus Therapeutics plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AUTL
News
- Asgard Therapeutics appoints Professor Dr Wolfram Brugger as Chief Medical Officer as it advances transformative ‘personalized off-the-shelf’ immunotherapy toward clinical developmentGlobeNewswire
- Autolus Therapeutics (AUTL) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $10.00 price target on the stock.MarketBeat
- Autolus Therapeutics Highlights obe-cel Momentum in ALL With New Real-World ROKA and Pediatric Data [Yahoo! Finance]Yahoo! Finance
- Autolus Therapeutics to Participate in Upcoming Investor ConferencesGlobeNewswire
- Mizuho Lowers its Price Target on Autolus Therapeutics plc (AUTL) to $10 from $12 [Yahoo! Finance]Yahoo! Finance
AUTL
Earnings
- 3/27/26 - Miss
AUTL
Sec Filings
- 4/16/26 - Form 8-K
- 4/15/26 - Form DEL
- 4/15/26 - Form DEL
- AUTL's page on the SEC website